San Diego, CA, United States of America

Xu Wu

USPTO Granted Patents = 8 


 

Average Co-Inventor Count = 3.4

ph-index = 4

Forward Citations = 52(Granted Patents)


Location History:

  • San Diego, CA (US) (2007 - 2013)
  • San Deigo, CA (US) (2013)
  • Lexington, MA (US) (2014 - 2020)

Company Filing History:


Years Active: 2007-2025

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Xu Wu: Innovator in TEAD Transcription Factor Inhibition

Introduction

Xu Wu is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of biochemistry, particularly in the development of small molecule inhibitors targeting TEAD transcription factors. With a total of 8 patents, his work is pivotal in advancing therapeutic options for diseases such as cancer.

Latest Patents

Xu Wu's latest patents include innovative compounds that inhibit the activity of TEAD transcription factors. The first patent focuses on small molecule inhibitors that are useful in treating diseases related to TEAD activity, including cancer. The second patent also addresses TEAD transcription factor autopalmitoylation inhibitors, which similarly aim to provide therapeutic benefits against diseases associated with TEAD.

Career Highlights

Throughout his career, Xu Wu has worked with notable organizations, including Irm LLC and The General Hospital Corporation. His expertise in the field has allowed him to develop groundbreaking solutions that address critical health challenges.

Collaborations

Xu Wu has collaborated with esteemed colleagues such as Qiang Ding and Yahua Liu, contributing to a rich environment of innovation and research.

Conclusion

Xu Wu's contributions to the field of biochemistry, particularly through his patents on TEAD transcription factor inhibitors, highlight his role as a key innovator. His work continues to pave the way for advancements in the treatment of serious diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…